BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4033069)

  • 1. Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays.
    Press MF; Holt JA; Herbst AL; Greene GL
    Lab Invest; 1985 Sep; 53(3):349-61. PubMed ID: 4033069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunocytochemical method for demonstrating estrogen receptor in human uterus using monoclonal antibodies to human estrophilin.
    Press MF; Greene GL
    Lab Invest; 1984 Apr; 50(4):480-6. PubMed ID: 6368973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoclonal antibodies in immunocytochemical localization of estrogen receptors in ovarian cancer.
    Masood S
    Cancer Detect Prev; 1988; 12(1-6):283-90. PubMed ID: 3052833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
    McCarty KS; Szabo E; Flowers JL; Cox EB; Leight GS; Miller L; Konrath J; Soper JT; Budwit DA; Creasman WT
    Cancer Res; 1986 Aug; 46(8 Suppl):4244s-4248s. PubMed ID: 3524805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas.
    Holt JA; Lyttle CR; Lorincz MA; Stern SD; Press MF; Herbst AL
    J Natl Cancer Inst; 1981 Aug; 67(2):307-18. PubMed ID: 6943370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.
    Charpin C; Martin PM; Jacquemier J; Lavaut MN; Pourreau-Schneider N; Toga M
    Cancer Res; 1986 Aug; 46(8 Suppl):4271s-4277s. PubMed ID: 3524808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.
    Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA
    Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies.
    Press MF; Nousek-Goebl NA; Greene GL
    J Histochem Cytochem; 1985 Sep; 33(9):915-24. PubMed ID: 4020102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy.
    Richman CM; Holt JA; Lorincz MA; Herbst AL
    Obstet Gynecol; 1985 Feb; 65(2):257-63. PubMed ID: 3969239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle.
    Press MF; Nousek-Goebl N; King WJ; Herbst AL; Greene GL
    Lab Invest; 1984 Nov; 51(5):495-503. PubMed ID: 6387273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.
    King WJ; DeSombre ER; Jensen EV; Greene GL
    Cancer Res; 1985 Jan; 45(1):293-304. PubMed ID: 3965140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor immunocytochemical assay (ER-ICA) in human endometrium.
    Charpin C; Martin PM; Lavaut MN; Pourreau-Schneider N; Toga M
    Int J Gynecol Pathol; 1986; 5(2):119-31. PubMed ID: 3522449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma.
    Holt JA; Lorincz MA; King WJ
    Obstet Gynecol; 1983 Aug; 62(2):231-5. PubMed ID: 6866366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.
    Budwit-Novotny DA; McCarty KS; Cox EB; Soper JT; Mutch DG; Creasman WT; Flowers JL; McCarty KS
    Cancer Res; 1986 Oct; 46(10):5419-25. PubMed ID: 3756890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody.
    Flowers JL; Seigler HF; McCarty KS; Konrath J; McCarty KS
    Arch Dermatol; 1987 Jun; 123(6):764-5. PubMed ID: 3555354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor localization in the female genital tract.
    Press MF; Nousek-Goebl NA; Bur M; Greene GL
    Am J Pathol; 1986 May; 123(2):280-92. PubMed ID: 2939725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of estrophilin in frozen sections of breast cancers using an estrogen receptor immunocytochemical assay.
    Ozzello L; De Rosa CM; Konrath JG; Yeager JL; Miller LS
    Cancer Res; 1986 Aug; 46(8 Suppl):4303s-4307s. PubMed ID: 2425948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.